Eli Lilly and Company logo

Director, Global Regulatory Affairs – CMC, Lifecycle Innovation

Eli Lilly and Company

Indianapolis, INOnsitePosted 2 days ago$177,000 - $308,000/year
Full TimeDirector & AboveRegulatory AffairsPharmaceutical
Original posting ↗

Summary

The Director, GRA-CMCD Lifecycle Innovation provides scientific, strategic, tactical and operational regulatory leadership for post-approval CMC activities across Lilly's parenteral product commercial portfolio. This role leads complex global lifecycle regulatory strategies across products and manufacturing sites, enabling high-quality, timely execution of post-approval changes while improving submission efficiency and simplifying regulatory processes.

Job description

Key Responsibilities

  • Deep technical knowledge and understanding of CMC molecule drug development and manufacturing science(s); broad technical knowledge of global CMC regulatory requirements and guidelines for reporting post-approval changes and updating global product registrations.
  • Provide high-quality, timely, and decisive regulatory advice to allow project teams to make well-informed decisions on product lifecycle planning; anticipate and resolve technical or operational issues that could impact submission timing.
  • Serve as regulatory lead for site additions and technology transfers, managing regulatory relationships with Lilly sites and external contract manufacturing organizations (CMOs) to ensure alignment on data packages and submission timelines.
  • Develop and implement post-approval regulatory strategies for assigned products and sites, defining filing approaches and data expectations for site changes, analytical updates, specification changes, site additions, and related lifecycle activities.
  • Lead preparation, review, and execution of variations, supplements, annual reports, DMFs, and related submissions; review and approve CMC documents for global submissions, including manufacturing changes, annual reports, and renewals.
  • Lead regulatory assessments for change controls and deviations for assigned products/sites, applying risk-based principles to categorize and prioritize post-approval changes.
  • Work closely with Manufacturing and Quality to develop compliant and scientifically sound data packages; coordinate with sites to ensure readiness and alignment on regulatory expectations and timelines.
  • Monitor emerging regulatory guidance related to lifecycle management and apply it strategically to current and future submissions; identify opportunities to simplify lifecycle processes or accelerate submissions.
  • Network with GRA, M&Q, and Business Unit leadership to build awareness and alignment on complex CMC regulatory strategies; serve as a regulatory point of contact for assigned manufacturing sites.
  • Contribute to implementation of digital tools supporting lifecycle management, including automated templates, digital submissions, and AI/ML applications.
  • Communicate lifecycle strategies, risks, and timelines clearly to sites and cross-functional partners; translate regulatory implications for operational and business stakeholders.
  • Supervision and/or mentoring of global regulatory affairs scientists, regulatory associates and teams as needed.

Basic Qualifications/Requirements

  • B.S. degree in a STEM field.
  • 7+ years of Regulatory CMC or technical CMC experience supporting post-approval lifecycle management of biologics, parenteral products, combination products, or related complex modalities.

Additional Skills/Preferences

  • Advanced degree (MSc, PharmD, or PhD) in chemistry, biology, biochemistry, pharmacy, or a related scientific discipline preferred.
  • Experience developing regulatory strategies, determining submission data packages, authoring CMC submission content for biologic and/or parenteral products and leading teams to deliver timely submissions.
  • Experience with marketing authorization application or post-approval change processes including response to questions.
  • Knowledge of major global regulatory procedures, regulations, and evolving expectations for post-approval lifecycle management, including change control, comparability, deviation assessments, and post-approval filings.
  • Relevant experience across CMC modalities relevant to Lilly's commercial portfolio (e.g., biologics, synthetic peptides, combination products, or other complex modalities), including drug substance, drug product, and analytical sciences considerations.
  • Experience with aseptic/sterile manufacturing processes, container closure integrity, and sterility assurance for parenteral drug products.
  • Extensive regulatory experience managing complex submission strategies, or equivalent combination of technical and regulatory expertise.
  • Experience planning for and participating in Health Authority interactions.
  • Demonstrated ability to assess and manage risk in a highly regulated and evolving lifecycle environment.
  • Strong written, verbal, and presentation communication skills.
  • Demonstrated leadership, with strong influencing and negotiation skills.
  • High attention to detail and commitment to quality.
  • Strong collaboration skills, with the ability to work effectively across diverse, cross-functional teams and multiple sites or CMOs.

Requirements

  • B.S. degree in a STEM field
  • 7+ years of Regulatory CMC or technical CMC experience supporting post-approval lifecycle management of biologics, parenteral products, combination products, or related complex modalities
  • Experience developing regulatory strategies, determining submission data packages, authoring CMC submission content for biologic and/or parenteral products and leading teams to deliver timely submissions
  • Experience with marketing authorization application or post-approval change processes including response to questions
  • Knowledge of major global regulatory procedures, regulations, and evolving expectations for post-approval lifecycle management, including change control, comparability, deviation assessments, and post-approval filings
  • Relevant experience across CMC modalities including drug substance, drug product, and analytical sciences considerations
  • Experience with aseptic/sterile manufacturing processes, container closure integrity, and sterility assurance for parenteral drug products
  • Extensive regulatory experience managing complex submission strategies, or equivalent combination of technical and regulatory expertise
  • Experience planning for and participating in Health Authority interactions
  • Demonstrated ability to assess and manage risk in a highly regulated and evolving lifecycle environment
  • Strong written, verbal, and presentation communication skills
  • Demonstrated leadership, with strong influencing and negotiation skills
  • High attention to detail and commitment to quality
  • Strong collaboration skills, with the ability to work effectively across diverse, cross-functional teams and multiple sites or CMOs

Benefits

  • 401(k) Matching
  • Pension
  • Vacation Benefits
  • Medical, Dental & Vision
  • Prescription Drug Benefits
  • Flexible Spending Accounts
  • Life Insurance
  • Death Benefits
  • Employee Assistance Program
  • Fitness Benefits
  • Company Bonus

Company overview

Eli Lilly and Company, commonly known as Lilly, is a leading American multinational pharmaceutical corporation headquartered in Indianapolis, Indiana. Founded in 1876 by Colonel Eli Lilly, the company has grown into one of the world's most valuable pharmaceutical enterprises, with operations in approximately 125 countries. Lilly specializes in developing and manufacturing innovative medicines across multiple therapeutic areas, including diabetes, oncology, neuroscience, immunology, and cardiometabolic diseases. The company is renowned for its groundbreaking work in insulin production, having been the first to mass-produce insulin and later developing the first commercially available insulin product in the U.S. Lilly's current portfolio includes blockbuster medications such as Mounjaro and Zepbound (tirzepatide) for diabetes and obesity, Trulicity (dulaglutide) for type 2 diabetes, Verzenio (abemaciclib) for breast cancer, and Taltz (ixekizumab) for autoimmune conditions. With approximately 47,000 employees worldwide, Lilly maintains a strong commitment to research and development, investing heavily in scientific innovation to address some of the world's most significant health challenges. The company operates with a mission to make life better for people around the world through the discovery and delivery of innovative medicines.

Explore more jobs of your matchFind more biopharma roles with GetBioJob.